In conversation with John Cipollo: antigen structure, glycosylation, and the future of vaccine design

Advances in mass spectrometry, glycomics, and structural analysis are increasingly informing vaccine antigen characterization and assessment. Working at the interface of regulatory science, analytical characterization, and immunology, John Cipollo explores how antigen structure and glycosylation relate to immune recognition, viral evolution, and vaccine performance.

John Cipollo, Research Chemist & Principal Investigator, Vaccine Structure Group, FDA CBER DBPAP

Please enter your email to access content Read now